Loss of memory (CD27) B lymphocytes in HIV-1 infection
- 1 May 2001
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 15 (8) , 957-964
- https://doi.org/10.1097/00002030-200105250-00003
Abstract
The mechanisms of B-cell dysfunction during HIV-1 infection, including polyclonal B-cell activation, are poorly understood. We studied the phenotype and the functionality of peripheral memory B cells in HIV-1-infected subjects. The phenotype of B cells and the responsiveness to T-cell dependent activation in vitro were analysed in 36 HIV-1-infected and 34 healthy subjects. Phenotyping of B and T cells was performed by FACS. IgG content was measured in plasma (by nephelometry) and cultures (by enzyme-linked immunosorbent assay) of B lymphocytes activated through CD40 or CD27 ligation. Expression of Fas and Fas ligand was performed by FACS on B-cell subpopulations from five HIV-1-infected and four uninfected subjects. The peripheral memory (CD27) B cells were significantly reduced in HIV-1-infected subjects. The amount of memory B cells was low in both drug-naive subjects and patients undergoing antiretroviral therapy. Ex vivo expression of CD70 (CD27 ligand) on T cells was significantly higher in HIV-1-infected subjects and inversely correlated with the frequency of memory B cells. In spite of the reduced number of memory B cells, in vitro spontaneous and activation-induced IgG secretion was higher in HIV-1-infected patients than in uninfected controls. The hyperactivation status of B lymphocytes in HIV-1-infected patients was further confirmed by the finding of upregulation of Fas and FasL expression on memory B cells. Memory B lymphocytes are depleted from peripheral blood in HIV-1-infected subjects. Our ex vivo findings suggest that persistent T-cell activation may contribute to loss of memory B cells through upregulation of Fas/FasL on these cells and terminal differentiation into plasma cells.Keywords
This publication has 39 references indexed in Scilit:
- CD27: a memory B-cell markerImmunology Today, 2000
- CD95 Ligand (CD95L) in Normal Human Lymphoid TissuesThe American Journal of Pathology, 1999
- HIV-1 Antigen–specific and –nonspecific B Cell Responses Are Sensitive to Combination Antiretroviral TherapyThe Journal of Experimental Medicine, 1998
- Synergistic augmentative effect of interleukin‐10 and CD27/CD70 interactions on B‐cell immunoglobulin synthesisImmunology, 1998
- Functional B Cell Abnormalities in HIV Type 1 Infection: Role of CD40L and CD70AIDS Research and Human Retroviruses, 1997
- Human antibodies from phage libraries: neutralizing activity against human immunodeficiency virus type 1 equally improved after expression as Fab and IgG in mammalian cellsEuropean Journal of Immunology, 1996
- Nef protein of HIV-1 has B-cell stimulatory activityAIDS, 1994
- Poor antibody response after tetanus and pneumococcal vaccination in immunocompromised, HIV-infected patientsClinical and Experimental Immunology, 1991
- The influence of HIV infection on antibody responses to a two-dose regimen of influenza vaccineJAMA, 1989
- Abnormalities of B-Cell Activation and Immunoregulation in Patients with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1983